Mayo Clinic Laboratories is committed to working with our communities as we all face the unprecedented challenges of the COVID-19 pandemic. Since early 2020, Mayo Clinic researchers and experts have provided expertise to guide the public health response, and our clinical staff has been on the front lines providing lifesaving care for patients with COVID-19.
Topic's Include: Biden: 2.8M people signed up for ObamaCare in special period, the pandemic marks another grim milestone of 1 in 500 Americans die of COVID-19, and understanding the delta variant, vaccines and breakthrough cases in Minnesota.
In this episode of Lab Medicine Rounds, Dr. Marshall Mazepa, Assistant Professor of Medicine at the University of Minnesota, discusses the topic of thrombotic thrombocytopenic purpura (TTP) and why it’s important to understand it.
As a regulatory affairs coordinator in Quality Management Services, it’s Corrisa Miliander’s job to report diseases to each state across the country as required by law — a crucial role that supports public health agencies as they work to monitor and control outbreaks of communicable diseases.
Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-calls laboratory testing and resources to industry partners conducing clinical research and trials.
Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for patients across a variety of specialities.
This weeks research roundup features: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19.
Topic's Include: Being vaccinated for COVID-19 means protection against more than severe illness, Vaccines to Variants, and COVID-19 variants mu, delta and what to know about mutations.
Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., reviews the results of a study that Mayo Clinic recently published comparing four different rapid antigen tests for novel coronavirus.
Topic's Include: Biden announces COVID-19 vaccine mandates that will affect 100 million Americans, how organ transplantation could become easier, starting at the U of M, and managing the pandemic that never seems to end.
In this episode of Lab Medicine Rounds, Dr. Meera Sridharan, Assistant Professor of Medicine and Oncology and senior associate consultant in the Department of Hematology at Mayo Clinic, discusses the evolving field of direct oral anticoagulant (DOAC) reversals and the critical advances being made.
Mayo Clinic Laboratories has been key to Minnesota’s COVID-19 testing strategy since the start of the pandemic. At their height in 2020, Mayo’s COVID-19 labs were running 24/7, processing up to 90,000 COVID-19 specimens a day. Dr. Morice explains what Mayo Clinic Laboratories is doing now to handle the latest surge.
PACE / State of CA / State of FLThis “Continual Improvement” webinar will share how boundless collaboration can be achieved when laboratory practices are standardized across multiple laboratory locations.
A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that provide inventive and essential solutions to broaden testing capabilities.